Spectral Medical Inc. named Richard Wieland as interim CFO.
Wieland was previously with LyphoMed as CFO until the pharmaceutical company was acquired by Fujisawa Pharmaceutical Co. Ltd.
Spectral Medical appoints interim CFO
A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research
2021 Year in Review: Highlighting Key Investment Banking Trends
Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings
Global M&A By the Numbers: Q3 2021
Spectral Medical Inc. named Richard Wieland as interim CFO.
Wieland was previously with LyphoMed as CFO until the pharmaceutical company was acquired by Fujisawa Pharmaceutical Co. Ltd.